A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical Trial

NCT01965418 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Liver Fibrosis
Chronic Hepatitis B

Interventions

DRUG: Fufang Biejia Ruangan Tablet
DRUG: Placebo

Sponsor

Beijing 302 Hospital